Maria Greenwald

Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks

Stanley Cohen, Paul Emery, Maria Greenwald et al. · Arthritis & Rheumatism · 2006 · 1.6K citations

Risedronate therapy prevents corticosteroid-induced bone loss : A twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

Stanley Cohen, Robert M. Levy, Michael Keller et al. · Arthritis & Rheumatism · 1999 · 615 citations

Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial

Clifton O. Bingham, R. John Looney, Atul Deodhar et al. · Arthritis & Rheumatism · 2009 · 458 citations

Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis

Philip J. Mease, Mark C. Genovese, Maria Greenwald et al. · New England Journal of Medicine · 2014 · 384 citations · Full text

Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study

Maxime Dougados, Désirée van der Heijde, Ying‐Chou Chen et al. · Annals of the Rheumatic Diseases · 2016 · 375 citations · Full text